Constellation Brands Inc. (STZ)

190.72
2.67 1.38
NYSE : Consumer Non-Durables
Prev Close 193.39
Open 191.04
Day Low/High 187.87 / 192.69
52 Wk Low/High 191.85 / 236.62
Volume 2.36M
Avg Volume 2.16M
Exchange NYSE
Shares Outstanding 166.14M
Market Cap 37.28B
EPS 13.50
P/E Ratio 12.21
Div & Yield 2.96 (1.28%)

Latest News

Tilray Is the Cannabis Wild Child Stock

Tilray Is the Cannabis Wild Child Stock

Citron's Andrew Left has maintained a short position throughout that would appear dangerous to most, yet he seems very confident.

What a Strong Dollar Means for the Market - Jim Cramer Breaks It Down

What a Strong Dollar Means for the Market - Jim Cramer Breaks It Down

TheStreet founder and Action Alerts Plus portfolio manager Jim Cramer breaks down Tuesday's market action.

Here's Why Tilray Stock Is the Wild Child

Here's Why Tilray Stock Is the Wild Child

Perhaps the highest profile impact on Tilray equity performance has been the interest of Andrew Left of Citron Research.

Tilray Stock Higher Ahead of First Post-Legalization Earnings Release

Tilray Stock Higher Ahead of First Post-Legalization Earnings Release

Tilray will have a lot to tackle this evening.

Bad News Is Good News: Cramer's 'Mad Money' Recap (Thursday 11/8/18)

Bad News Is Good News: Cramer's 'Mad Money' Recap (Thursday 11/8/18)

Cramer said the recent selloff has been good for investors because it reset expectations. Here's what he thinks about energy and the Fed.

Emerson Electric, Arista Networks, Foot Locker: 'Mad Money' Lightning Round

Emerson Electric, Arista Networks, Foot Locker: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Emerson Electric, Arista Networks, Foot Locker, SailPoint Technologies, Crown Holdings, Idexx Laboratories and more.

Adding 2 Names to the Bullpen

We are placing Five Below and Constellation Brands in the Bullpen as we hunt for more stocks levered to the consumer.

Jim Cramer's Take on the Cannabis Craze

Jim Cramer's Take on the Cannabis Craze

Another cannabis craze?

Focus on FOMC After Rip-Roaring Day for Stocks: Market Recon

Focus on FOMC After Rip-Roaring Day for Stocks: Market Recon

Consumer Discretionary stocks were the hottest on Wednesday, though all eleven sectors easily finished in the green.

Constellation Brands' $5 Billion CAD ($4 Billion USD) Investment In Canopy Growth Closes Following Shareholder And Canadian Government Approval

Constellation Brands' $5 Billion CAD ($4 Billion USD) Investment In Canopy Growth Closes Following Shareholder And Canadian Government Approval

VICTOR, NY and SMITHS FALLS, ON, Nov. 1, 2018 /PRNewswire/ - Constellation Brands, Inc.

Coca-Cola Not Going to Pot, Says CEO

Coca-Cola Not Going to Pot, Says CEO

Coca-Cola CEO James Quincey says the company has no plans to develop drinks or any other products infused with CBD, the non-psychoactive ingredient in marijuana.

Tinley CEO on the Future of Marijuana-Infused Beverages

Tinley CEO on the Future of Marijuana-Infused Beverages

Tinley's CEO talks about its cannabis-infused beverages.

How Canopy Growth Benefitted From Partnering With Snoop Dog

How Canopy Growth Benefitted From Partnering With Snoop Dog

Rapid growth in cannabis industry is fueling new competition

Tariffs and the Fed: Cramer's 'Mad Money' Recap (Wednesday 10/24/18)

Tariffs and the Fed: Cramer's 'Mad Money' Recap (Wednesday 10/24/18)

This is serious: The market is ignoring legitimate, positive earnings, says Jim Cramer, and tariffs and rates are the culprits.

The Rally We've Been Waiting For: Cramer's 'Mad Money' Recap (Tuesday 10/16/18)

The Rally We've Been Waiting For: Cramer's 'Mad Money' Recap (Tuesday 10/16/18)

Panic is not an investment strategy, says Jim Cramer. But when everyone else is panicking, that's when you need to buy.

Gatorade-Like Cannabis Drink to Soothe Aches? Constellation Brands Says 'Yes'

Gatorade-Like Cannabis Drink to Soothe Aches? Constellation Brands Says 'Yes'

Jim Cramer talked legal weed with Bill Newlands of Constellation Brands and Bruce Linton of Canopy Growth.

The Game Plan: Cramer's 'Mad Money' Recap (Friday 9/28/18)

The Game Plan: Cramer's 'Mad Money' Recap (Friday 9/28/18)

Jim Cramer looks ahead to the fourth quarter and has your game plan for next week.

Behind the Selloff: Cramer's 'Mad Money' Recap (Thursday 10/4/18)

Behind the Selloff: Cramer's 'Mad Money' Recap (Thursday 10/4/18)

Jim Cramer lists the things we need to see before the bear backs off and the market regains its footing.

Anheuser-Busch InBev, Alteryx, Walker & Dunlop: 'Mad Money' Lightning Round

Anheuser-Busch InBev, Alteryx, Walker & Dunlop: 'Mad Money' Lightning Round

Jim Cramer weighs in on Anheuser-Busch InBev, Alteryx, Walker & Dunlop, Kratos Defense & Security, Johnson Controls, Nektar Therapeutics, Align Technology.

Listen to the CEOs: Cramer's 'Mad Money' Recap (Tuesday 10/9/18)

Listen to the CEOs: Cramer's 'Mad Money' Recap (Tuesday 10/9/18)

Jim Cramer is concerned about risk, and the Fed. But, he says, you need to get in there and talk with the CEOs to get the real story about the economy.

Tech Doesn't Have Good Defense: Cramer's 'Mad Money' Recap (Thursday 9/6/18)

Tech Doesn't Have Good Defense: Cramer's 'Mad Money' Recap (Thursday 9/6/18)

Jim Cramer, celebrating the opening of the NFL season, says this is just another day of total tech mayhem.

Cannabis: Why It May End Up in Your Portfolio

Cannabis: Why It May End Up in Your Portfolio

Cannabis is everywhere these days -- including in the news headlines.

United Parcel Service, TJX Companies: 'Mad Money' Lightning Round

United Parcel Service, TJX Companies: 'Mad Money' Lightning Round

Jim Cramer takes a look at United Parcel Service, TJX Companies, Anheuser-Busch InBev, Fiat Chrysler, AbbVie, Nvidia, Excelixis, Bank of America, Endo Pharmaceutical and more.

Disrupt It or Bust It: Cramer's 'Mad Money' Recap (Monday 8/20/18)

Disrupt It or Bust It: Cramer's 'Mad Money' Recap (Monday 8/20/18)

Companies, like PepsiCo and Constellation, need to constantly reinvent themselves, or they'll get crushed. It's a tough battle, Jim Cramer says.

What Barclays Gets Wrong About Cannabis and Tobacco

What Barclays Gets Wrong About Cannabis and Tobacco

Cannabis and tobacco are hard to equate, which Barclays' primer on the Cannabis industry misses.

Tinley CEO Jeff Maser Breaks Down the Beverage Industry

Tinley CEO Jeff Maser Breaks Down the Beverage Industry

Tinley CEO Jeff Maser talks about the beverage industry and its interactions with marijuana.

Constellation Brands Shows a Curious Mix of Charts and Indicators

Constellation Brands Shows a Curious Mix of Charts and Indicators

Constellation Brands is the kind of company that typically does well in a weak market environment.

CGC Is the One Must-Own Cannabis Stock

CGC Is the One Must-Own Cannabis Stock

Canopy Growth already has a $4 billion war chest thanks to Constellation Brands.

TheStreet Quant Rating: A- (Buy)